The Impact Of Dura Pharmaceuticals On Private Securities Fraud Actions
Stephen M. Sinaiko and Brendan Schulman's article "The Impact Of Dura Pharmaceuticals On Private Securities Fraud Actions" appeared in the June 2005 issue of The Metropolitan Corporate Counsel.
We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.